Business
NEUPATH HEALTH ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID
NeuPath Health Inc. (TSXV:NPTH) ( NeuPath or the “ Company ”) announced tod...
About this update from Neupath Health Inc.
[{"type":"text","content":"NEUPATH HEALTH ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n \n\n\n\n NeuPath Health Inc. (TSXV:NPTH) (\n \n NeuPath\n \n or the “\n \n Company\n \n ”) announced today that the TSX Venture Exchange (the “\n \n Exchange\n \n ”) has accepted a notice filed by NeuPath of its intention to renew its normal course issuer bid (“\n \n NCIB\n \n ”).\n \n\n Under the NCIB, the Company may, during the 12-month period commencing December 4, 2025 and ending December 3, 2026 (or on such date that the Company completes its purchases or provides notice of termination), purchase up to 2,527,224 common shares (“\n \n Shares\n \n ”) in total, being approximately 4.5% of the total number of Shares outstanding as at December 3, 2025 being 56,160,537 Shares. The price which the Company will pay for any such Shares will be the prevailing market price at the time of acquisition. Also, in accordance with the policies of the Exchange, the Company may not purchase more than 2% of its issued and outstanding Shares during any 30-day period. The actual number of Shares which may be purchased pursuant to the NCIB and the timing of any such purchases, outside of restricted periods, will be determined by management of the Company.\n \n\n Purchases under the NCIB will be made from time to time by Acumen Capital Finance Partners Limited (the “\n \n Broker\n \n ”) on behalf of the Company through the facilities of the Exchange or through a Canadian alternative trading system. The Company has entered into a pre-defined plan with the Broker to allow for the purchase of Shares under the NCIB at times when the Company ordinarily would not be permitted to purchase Shares due to its internal trading black-out periods, insider trading rules or regulatory restrictions. The plan provides a set of standard instructions to the Broker to make purchases at its sole discretion under the NCIB in accordance with the terms set out in such plan, the rules of the Exchange and applicable securities laws. Decisions regarding any future repurchases will depend on certain factors, such as market conditions, share price and instructions set forth in the plan. The Company may elect to suspend or discontinue share repurchases at any time in accordance ...